UK is planning to use nuclear waste for cancer treatment. It'll harvest lead-212, a powerful therapeutic radionuclide, from recycled nuclear materials, to create Targeted Alpha Therapies, an emerging class of precision medicines that kill cancer cells with accuracy while minimising damage to healthy tissue. Tiny quantities of lead-212 can treat thousands, making the supply secure and scalable.